Trial Profile
An Open Label, Randomized, Single-dose, 4-period Cross-over Study to Compare the Pharmacokinetics and Safety Following Administration of JLP-1401 and Coadministration of Rosuvastatin and Telmisartan/Amlodipine in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary) ; Amlodipine/telmisartan; Rosuvastatin
- Indications Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 21 Dec 2017 Status changed from recruiting to completed.
- 15 Aug 2017 New trial record